When patient safety, regulatory approval and real-world effectiveness are on the line, AI can't act autonomously.

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

In this interview, NewsMedical talks to Amanda Jones at Revvity about the strategies and solutions available to revolutionize the landscape of R&D in clinical research. Can you describe some of the ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

With the European Medicines Agency (EMA) adopting a recommendation report to streamline the clinical procedures for ...

Health systems and their technology vendors can work together to modernize clinical process maps using artificial intelligence – transforming them from static reference documents into living guidance ...

SYDNEY--(BUSINESS WIRE)--Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, has published a report analyzing recent trends in obesity-related clinical ...

TEMECULA, CALIFORNIA , UNITED STATES, February 10, 2026 /EINPresswire.com/ — Dr. Dayan Goodenowe, author of Breaking Alzheimer’s, will present a formal FDA ...

Investing.com — Artificial intelligence is accelerating drug development and lowering costs across the pharmaceutical industry, potentially boosting operating profits by more than 10%, according to ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and ...